AIDS test kit LF
COVID-19infectionvirus

AIDS test kit - LF  - Aidian Oy - COVID-19 / infection / virus
AIDS test kit - LF  - Aidian Oy - COVID-19 / infection / virus
Add to favorites
Compare this product
 

Characteristics

Applications
AIDS, COVID-19, infection
Micro-organism
virus, SARS-COV-2
Sample type
nasal
Analysis mode
immunochromatographic
Result display time

Max.: 20 min

Min.: 15 min

Specificity

99.3 %

Sensitivity

93.5 %

Description

Aidian LF SARS-CoV-2 Ag Test is a rapid and reliable test for detecting SARS-CoV-2 antigens in nasal swab specimens at point of care. Generally Aidian LF SARS-CoV-2 Ag Test is an immunochromatographic in vitro test for qualitative detection of SARS-CoV-2 nucleocapsid protein from nasal swab samples. The test results can be used as aid in diagnosing COVID-19 infection. COVID-19, caused by SARS-CoV-2, is an infectious disease with symptoms ranging from mild to severe. COVID-19 is transmitted easily, and rapid identification of infected persons aids in cutting transmission routes. The test is most suitable when they are used as a diagnostic aid for persons who have recently become symptomatic and the virus load in the respiratory tract is high.1,2 Advantages of Aidian LF SARS-CoV-2 Ag Test Easy test procedure Only a few steps required All materials necessary to perform the test are included in the kit Storage at room temperature (2-30°C) No need for additional instrument Reliable test results at the point of care Detects SARS-CoV-2 nucleoproteins The test result is used for early detection of a possible infection by healthcare professionals. A confirmation test is necessary. Aidian LF SARS-CoV-2 Ag Test is not registered in the USA.

Catalogs

No catalogs are available for this product.

See all of Aidian Oy‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.